Seelos Therapeutics Inc (Nasdaq:SEEL) announced Friday a $6.7 million registered direct share offering with certain institutional investors. The clinical-stage biopharmaceutical company is offering 4,475,000 shares of its common stock at a price of $1.50 per share, according to a statement. Seelos also will issue unregistered warrants for the purchase of up to 2,237,500 shares of common stock in a concurrent private placement. The warrants have an exercise price of $1.78 per share of common stock, and will be exercisable six months from the date of issuance and expire four years afterwards.
CROP Infrastructure Corp (CSE:CROP) (OTCMKTS:CRXPF) hit a new milestone this week with the completion of its first harvest of 2019. The plants from the Vancouver-based cannabis company’s California greenhouses have all been dried and are waiting to be trimmed, the company said in a release Friday. Following this harvest, the greenhouses will be replanted for an additional harvest expected in October.
eWellness Healthcare Corporation (OTCMKTS:EWLL) revealed on Friday that one of the largest third-party insurance administrators in the US, with patients in all 50 states, has commenced referring worker compensation patients to the company. In a filing, the company said that, Initially, its PHZIO telemedicine platform will be used to treat patients in five states: California, New Jersey, Georgia, Tennessee and Arizona.
Fura Gems Inc (CVE:FURA) (OTCMKTS:FUGMF) said Friday that it has agreed amended terms to its previously announced acquisition of a ruby prospecting license in the Montepuez district of Cabo Delgado province in Mozambique. In July last year, the firm struck a share purchase agreement with vendor Azores Overseas Inc (Azores) over the acquisition of a 100% interest in the license No. 5572L.
Hemispherx Biopharma Inc (NYSEAmerican:HEB) said Friday that it is set to debut with a new name, AIM ImmunoTech Inc and trading symbol “AIM” on September 30. The Ocala, Florida-based company’s stock will continue to trade on the NYSE American, which is also referred to as the NYSE MKT. In a statement, the company said it is changing its name to reflect what it does as an immuno-tech company focused on the development of immunological agents to treat multiple cancers and immune deficiency diseases. The company is making steady progress with its flagship drug Ampligen that is in clinical trials to treat multiple cancers and expects results from ongoing clinical trials over the next 18 months to act as strong value drivers for the stock.
Pressland, a wholly owned subsidiary of Codebase Ventures Inc (CSE:CODE) (OTCQB:BKLLF), announced Friday it has entered into a development partnership with All Tech Is Human, a startup organization that acts as a catalyst and connector for tech change. In a statement, Pressland said it and New York-based All Tech Is Human have signed a non-binding letter of intent to work together to solve the ongoing issues of media trust and transparency. Pressland is building a data-management platform designed to serve organizations on the front line in the fight against fake news. The company is based in Brooklyn with team members distributed globally from Bangkok to Vancouver. All Tech Is Human is creating a hub for the ethical technology ecosystem that promotes knowledge-sharing and collaboration, tackling the thorniest tech/society issues.
RNC Minerals (TSE:RNX) told investors on Friday that it has begun mining operations at the Baloo Stage I open pit in Western Australia. The Baloo Stage I open pit is the first of a series of open pits that RNC is aiming to put into production to feed the Higginsville Gold Operations (HGO) plant, which was acquired by the gold producer in June. Baloo Stage I is expected to provide HGO with around 30,000 tons per month until the end of the year, RNC said in a statement.
Medallion Resources Ltd (CVE:MDL) (OTCMKTS:MLLOF) revealed Friday it has raised C$564,120 having closed the first tranche of its C$798,000 non-brokered private placing announced on August 2 this year. The proceeds of this financing will go towards trade-off and process engineering design studies, pilot plant planning, customer and feedstock supply development, and general working capital, the Vancouver-based firm, which wants to produce rare earth elements from monazite, said in a statement.
Ximen Mining Corp. (CVE:XIM) (OTCMKTS:XXMMF) has said it will begin a comprehensive roadshow campaign across North America and Europe, meeting with analysts, institutional investors, fund managers, brokers and high net-worth individuals. In a statement, Ximen said its busy schedule will begin with a shareholder awareness campaign in Toronto, Montreal and Quebec City in late September. Ximen said it will be concluding its European tour in London at the Mines & Money show on November 25 to 27.
Braingrid Limited (CSE:BGRD) has announced that further to its press releases, dated June 18, 2019 and August 8, 2019, European High Growth Opportunities Securitization Fund - advised by Alpha Blue Ocean Inc. - has converted $160,000 of its $690,000 remaining principal amount of senior unsecured convertible debentures into 2,000,000 common shares of the company at an effective price of $0.08 per share. Under the agreement between the fund and the company, executed June 11, 2019, Braingrid has a cumulative make whole obligation to the fund of $294,200, payable either in shares or cash at the company's discretion, if cash the obligation would be netted against future debenture issuances.
Berkwood Resources Ltd. (CVE:BKR) said TSX Venture Exchange approval has been granted to its acquisition of six selected groups of claims, consisting of 58 claims covering 3,116 hectares adjacent to its Lac Gueret South project. The company now holds a 100% interest in the property. Consideration for the acquisition of the new claims comprised the payment to the vendors of $11,500 and the issuance of 1.95 million common shares.